Equities

PZ Cussons Plc

PZC:LSE

PZ Cussons Plc

Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (GBX)79.60
  • Today's Change2.50 / 3.24%
  • Shares traded774.18k
  • 1 Year change-0.50%
  • Beta0.8978
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year PZ Cussons Plc had relatively flat revenues (527.90m to 513.80m), though the company grew net income from a loss of 57.00m to a smaller loss of 5.80m.
Gross margin40.25%
Net profit margin-1.01%
Operating margin4.07%
Return on assets-0.82%
Return on equity-2.51%
Return on investment-1.23%
More ▼

Cash flow in GBPView more

In 2025, cash reserves at PZ Cussons Plc fell by 6.20m. However, the company earned 23.50m from its operations for a Cash Flow Margin of 4.57%. In addition the company generated 700.00k cash from investing, though they paid out 28.70m more in financing than they received.
Cash flow per share0.0165
Price/Cash flow per share49.46
Book value per share0.5231
Tangible book value per share-0.0814
More ▼

Balance sheet in GBPView more

PZ Cussons Plc has a Debt to Total Capital ratio of 44.62%, a lower figure than the previous year's 70.16%.
Current ratio0.9771
Quick ratio0.6858
Total debt/total equity0.7829
Total debt/total capital0.4462
More ▼

Growth rates in GBP

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 89.83%. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)3.11%
Div growth rate (5 year)-9.10%
Payout ratio (TTM)--
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		89.79
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.